Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Heron

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Gastroenterology Clinics of North America|August 26, 2017
Update on Therapeutic Drug Monitoring in Crohn's DiseaseValérie Heron, Waqqas Afif
Gastroenterology Clinics of North America|October 30, 2020
Nonbiologic Immune Suppression in Ulcerative ColitisValérie Heron, Edward V Loftus
Inflammatory Bowel Diseases|May 23, 2022
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsMohammad Shehab, Fatema Alrashed, Valérie Heron, et al.
Endoscopy International Open|December 5, 2017
Validating bowel preparation scalesValérie Heron, Robin Parmar, Charles Ménard, et al.
Journal of the Canadian Association of Gastroenterology|April 15, 2021
Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn's DiseaseChristine Verdon, Niels Vande Casteele, Valérie Heron, et al.
Case Reports in Gastroenterology|July 13, 2016
Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on AzathioprineValérie Heron, Kyle Joshua Fortinsky, Gillian Spiegle, et al.
Journal of the Canadian Association of Gastroenterology|May 13, 2020
Endoscopist-Directed Propofol as an Adjunct to Standard Sedation: A Canadian ExperienceValérie Heron, Charlotte Golden, Seymour Blum, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Comparison of the Boston Bowel Preparation Scale with an Auditable Application of the US Multi-Society Task Force GuidelinesValérie Heron, Myriam Martel, Talat Bessissow, et al.
Crohn'S & Colitis 360|February 13, 2023
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center ExperienceGuilherme Piovezani Ramos, Badr Al-Bawardy, Manuel Bonfim Braga Neto, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Gastroenterology Clinics of North America|August 26, 2017
Update on Therapeutic Drug Monitoring in Crohn's DiseaseValérie Heron, Waqqas Afif
Gastroenterology Clinics of North America|October 30, 2020
Nonbiologic Immune Suppression in Ulcerative ColitisValérie Heron, Edward V Loftus
Inflammatory Bowel Diseases|May 23, 2022
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsMohammad Shehab, Fatema Alrashed, Valérie Heron, et al.
Endoscopy International Open|December 5, 2017
Validating bowel preparation scalesValérie Heron, Robin Parmar, Charles Ménard, et al.
Journal of the Canadian Association of Gastroenterology|April 15, 2021
Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn's DiseaseChristine Verdon, Niels Vande Casteele, Valérie Heron, et al.
Case Reports in Gastroenterology|July 13, 2016
Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on AzathioprineValérie Heron, Kyle Joshua Fortinsky, Gillian Spiegle, et al.
Journal of the Canadian Association of Gastroenterology|May 13, 2020
Endoscopist-Directed Propofol as an Adjunct to Standard Sedation: A Canadian ExperienceValérie Heron, Charlotte Golden, Seymour Blum, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Comparison of the Boston Bowel Preparation Scale with an Auditable Application of the US Multi-Society Task Force GuidelinesValérie Heron, Myriam Martel, Talat Bessissow, et al.
Crohn'S & Colitis 360|February 13, 2023
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center ExperienceGuilherme Piovezani Ramos, Badr Al-Bawardy, Manuel Bonfim Braga Neto, et al.
Pageof 1